Albendazole
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00518 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | alveolar echinococcosis | KG + DL |
| 2 | coenurosis | KG + DL |
| 3 | Cestode infectious disease | KG + DL |
| 4 | dermatofibrosarcoma protuberans | KG + DL |
| 5 | lung benign neoplasm | KG + DL |
| 6 | lung hilum carcinoma | KG + DL |
| 7 | inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia | KG + DL |
| 8 | fibroma of lung | KG + DL |
| 9 | hamartoma of lung | KG + DL |
| 10 | intestinal helminthiasis | KG + DL |
| 11 | fibromatosis, gingival | KG + DL |
| 12 | fibroblastic neoplasm | KG + DL |
| 13 | conventional fibrosarcoma | KG + DL |
| 14 | kidney fibrosarcoma | KG + DL |
| 15 | pulmonary sulcus neoplasm | KG + DL |
| 16 | lung germ cell tumor | KG + DL |
| 17 | junctional epidermolysis bullosa | KG + DL |
| 18 | Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome | KG + DL |
| 19 | heart fibrosarcoma | KG + DL |
| 20 | ovarioleukodystrophy | KG + DL |
| 21 | low grade fibromyxoid sarcoma | KG + DL |
| 22 | lung cancer | KG + DL |
| 23 | Marfan syndrome | KG + DL |
| 24 | aseptic meningitis | KG + DL |
| 25 | benign PEComa | KG + DL |
| 26 | lymphangiomyoma | KG + DL |
| 27 | uterine corpus perivascular epithelioid cell tumor | KG + DL |
| 28 | diaphragmatic or abdominal wall malformation | KG + DL |
| 29 | junctional epidermolysis bullosa, non-Herlitz type | KG + DL |
| 30 | dehydratase deficiency | KG + DL |
| 31 | situs inversus | KG + DL |
| 32 | cutis laxa - Marfanoid syndrome | KG + DL |
| 33 | lung PEComa | KG + DL |
| 34 | paralytic facial malformation | KG + DL |
| 35 | hypoglossia/aglossia | KG + DL |
| 36 | digestive tract malformation | KG + DL |
| 37 | external auditory canal aplasia/hypoplasia | KG + DL |
| 38 | congenital limb malformation | KG + DL |
| 39 | facial cleft | KG + DL |
| 40 | malformation syndrome with hamartosis | KG + DL |
| 41 | pseudodiastrophic dysplasia | KG + DL |
| 42 | fascioliasis | KG + DL |
| 43 | heart position anomaly | KG + DL |
| 44 | tuberous sclerosis | KG + DL |
| 45 | myiasis | KG + DL |
| 46 | cutaneous undifferentiated pleomorphic sarcoma | KG + DL |
| 47 | cleft lip with or without cleft palate | KG + DL |
| 48 | laterality defects, autosomal dominant | KG + DL |
| 49 | wound myiasis | KG + DL |
| 50 | furuncular myiasis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.